Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Apr 26 LDOS Leidos (LDOS) Advances But Underperforms Market: Key Facts
Apr 26 FUSN Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Apr 26 SRPT How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Apr 26 FUSN Top 4 Health Care Stocks That May Plunge This Month
Apr 25 FUSN Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Apr 25 VNDA UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
Apr 25 LDOS Huntington Ingalls (HII) Reports Next Week: Wall Street Expects Earnings Growth
Apr 25 SRPT Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
Apr 25 SRPT Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
Apr 25 VNDA Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Apr 24 VNDA Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
Apr 24 LDOS Leidos (LDOS) Rises Higher Than Market: Key Facts
Apr 24 VNDA Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Apr 24 LDOS Leidos (LDOS) to Report Q1 Earnings: What's in the Cards?
Apr 24 LDOS With 77% ownership in Leidos Holdings, Inc. (NYSE:LDOS), institutional investors have a lot riding on the business
Apr 24 LDOS Is Most-Watched Stock Leidos Holdings, Inc. (LDOS) Worth Betting on Now?
Apr 24 SRPT Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Apr 23 FUSN Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note
Apr 22 VNDA Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Apr 22 VNDA US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags